- Home
- JKHY vs SNN Comparison
JKHY vs SNN Comparison
Compare JKHY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKHY | SNN |
|---|---|---|
| Founded | 1976 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 13.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | JKHY | SNN |
|---|---|---|
| Price | $178.33 | $32.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $185.60 | $32.83 |
| AVG Volume (30 Days) | ★ 777.3K | 568.5K |
| Earning Date | 02-03-2026 | 02-24-2026 |
| Dividend Yield | 1.30% | ★ 2.23% |
| EPS Growth | 20.28 | ★ 59.91 |
| EPS | ★ 6.58 | 0.56 |
| Revenue | $2,419,044,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $7.52 | $7.71 |
| Revenue Next Year | $6.26 | $5.23 |
| P/E Ratio | ★ $27.11 | $28.42 |
| Revenue Growth | ★ 7.75 | 5.35 |
| 52 Week Low | $144.12 | $23.69 |
| 52 Week High | $196.00 | $38.79 |
Technical Indicators
Market Signals| Indicator | JKHY | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 45.58 | 44.98 |
| Support Level | $184.65 | $32.42 |
| Resistance Level | $186.90 | $33.25 |
| Average True Range (ATR) | 2.87 | 0.33 |
| MACD | -1.48 | 0.06 |
| Stochastic Oscillator | 8.26 | 56.30 |
Price Performance
Historical ComparisonAbout JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.